(NYSE: CVS) Cvs Health's forecast annual revenue growth rate of 4.99% is not forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 6.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.
Cvs Health's revenue in 2024 is $357,776,000,000.On average, 9 Wall Street analysts forecast CVS's revenue for 2024 to be $466,330,513,900,326, with the lowest CVS revenue forecast at $460,421,465,282,664, and the highest CVS revenue forecast at $468,157,076,661,083. On average, 9 Wall Street analysts forecast CVS's revenue for 2025 to be $490,966,479,843,006, with the lowest CVS revenue forecast at $466,214,911,465,938, and the highest CVS revenue forecast at $504,994,360,380,067.
In 2026, CVS is forecast to generate $523,086,850,498,133 in revenue, with the lowest revenue forecast at $493,770,929,638,069 and the highest revenue forecast at $550,682,107,127,326.